ACRX | AcelRx Pharmaceuticals Inc 1.34 -0.03 (-2.28%)
Category: Consumer goods
Industry: Drug Manufacturers - Major Quick infos Trade prices Volume: Market Cap: Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends:
Earnings History Date EPS / Forecast Revenue / Forecast November 5, 2020 - / -0.08- / 2.83MAugust 10, 2020 -0.08 / -0.132.92M / 2.02MBeat! May 11, 2020 -0.2 / -0.17386K / 1.97MBeat! March 16, 2020 -0.18 / -0.2475K / 1.01MBeat! November 6, 2019 -0.16 / -0.21608K / 962.32Kview more
Historical Data Date Price Open High Low Vol Change ER Dec 11, 2020 1.410 1.440 1.440
1.370
749.24K -0.7% Dec 10, 2020 1.420 1.320 1.460
1.270
2.26M 2.16% Dec 9, 2020 1.390 1.420 1.460
1.355
1.50M -4.14% Dec 8, 2020 1.450 1.466 1.470
1.400
1.48M -0.68% Dec 7, 2020 1.460 1.510 1.550
1.460
817.80K -3.95% Dec 4, 2020 1.520 1.450 1.550
1.420
1.18M 6.29% Dec 3, 2020 1.430 1.460 1.460
1.420
848.98K -2.72% Dec 2, 2020 1.470 1.476 1.500
1.400
669.22K 0.68% Dec 1, 2020 1.460 1.540 1.540
1.460
839.12K -2.67% Nov 30, 2020 1.500 1.520 1.540
1.460
721.22K -1.32% view more
News
October 7, 2020 12:00 PM EDT : AcelRx to Host Virtual KOL Event on Perioperative Use of DSUVIA® ir.acelrx.com Oct 8, 2020 AcelRx awarded ~$3.6M contract for DSUVIA by U.S. Army seekingalpha.com Sep 23, 2020 12:31 am September 16, 2020 4:00 PM EDT : Cantor Fitzgerald Virtual Global Healthcare Conference ir.acelrx.com Sep 17, 2020 4:00 am September 14, 2020 4:30 PM EDT : H.C. Wainwright & Co. 22nd Annual Global Investment Conference ir.acelrx.com Sep 15, 2020 4:30 am AcelRx announces DSUVIA's expanded access seekingalpha.com Sep 14, 2020 9:51 pm AcelRx initiates study of DSUVIA in the perioperative setting in orthopedic surgery seekingalpha.com Aug 24, 2020 10:12 pm
AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results finance.yahoo.com Aug 12, 2020 4:01 pm
AcelRx Pharmaceuticals (ACRX) Moves to Buy: Rationale Behind the Upgrade finance.yahoo.com Aug 11, 2020 12:00 pm
AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Lags Revenue Estimates finance.yahoo.com Aug 10, 2020 5:45 pm AcelRx Pharma up 6% on data supporting preop use of pain med Dsuvia seekingalpha.com Aug 19, 2020 10:00 pm August 10, 2020 4:30 PM EDT : AcelRx Second Quarter 2020 Financial Results Conference Call ir.acelrx.com Aug 11, 2020 4:30 am AcelRx Pharmaceuticals EPS beats by $0.06, beats on revenue seekingalpha.com Aug 11, 2020 4:05 am
AcelRx Pharmaceuticals Reports Second Quarter 2019 Financial Results finance.yahoo.com Aug 9, 2020 4:05 pm
AcelRx Pharmaceuticals Reports Third Quarter 2019 Financial Results finance.yahoo.com Aug 9, 2020 4:05 pm
AcelRx Pharmaceuticals Reports First Quarter 2020 Financial Results finance.yahoo.com Aug 9, 2020 4:01 pm
AcelRx Pharmaceuticals, Inc. to Host Earnings Call finance.yahoo.com Aug 9, 2020 2:30 pm
SHAREHOLDER ALERT: WeissLaw LLP Investigates Tetraphase Pharmaceuticals, Inc. finance.yahoo.com Aug 9, 2020 1:47 pm
Catalyst Gives Preliminary Firdapse Estimates & Other Updates finance.yahoo.com Aug 9, 2020 9:17 am
AcelRx Pharmaceuticals: Q4 Earnings Insights finance.yahoo.com Aug 9, 2020 9:02 am
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase finance.yahoo.com Aug 9, 2020 8:30 am Talk about AcelRx Pharmaceuticals Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon While many books explain the how of bitcoin, The Internet of Money delves into the why of bitcoin. Acclaimed information-security expert and author of Mastering Bitcoin, Andreas M. Antonopoulos examines and contextualizes the significance of bitcoin through a series of essays spanning the exhilarating maturation of this technology.